Treatment abandonment and refusal among children with central nervous system tumors in Jordan

被引:3
|
作者
Amayiri, Nisreen [1 ]
Bouffet, Eric [2 ]
机构
[1] King Hussein Canc Ctr, Div Pediat Hematol Oncol, 202 Queen Rania Al Abdullah St,POB 1269, Amman 11941, Jordan
[2] Hosp Sick Children, Div Hematol Oncol, Toronto, ON, Canada
关键词
abandonment; LMIC; pediatric CNS tumors; ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER;
D O I
10.1002/pbc.29054
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Treatment abandonment and refusal are reported to contribute significantly to poor survival of children with cancer in low- and middle-income countries. We aimed to assess this phenomenon among children diagnosed with central nervous system (CNS) tumors in Jordan. Methods We retrospectively reviewed the medical charts of children <18 years diagnosed with CNS tumors (2010-2020). Patients who abandoned or refused part of treatment were reviewed for their clinical characteristics, social circumstances, and possible reasons. We excluded patients referred for second opinion, radiotherapy only, or who traveled abroad for treatment. Results Four hundred seventy-three Jordanian children were identified; 12 families (2.5%) abandoned treatment, and 15 refused part of therapy (3%). Most patients were females (67%) and most had good or moderate performance status (89%). Most families (93%) lived within 2 hours from King Hussein Cancer Center. Most parents were university graduates (71%) and all fathers were employed, while 71% of mothers were housewives. The most common reasons to abandon or refuse therapy were treatment intensity in view of poor tumor outcome or bad quality of life, conflicting recommendations from other health care providers, "personal beliefs" against chemotherapy, and preference to use alternative medicine. Conclusions Treatment abandonment and refusal in Jordanian children with CNS tumors is low. Universal cancer insurance, high level of education in the country, centralized cancer care in one institution, and the twinning program likely contributed to our low incidence. Improving knowledge on CNS tumors and better community rehabilitation and supportive services may help further decrease the abandonment and treatment refusal rate.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Racial and ethnic disparities among children with primary central nervous system tumors in the US
    Nieblas-Bedolla, Edwin
    Christophers, Briana
    Williams, John R.
    Power-Hays, Alexandra
    Jimenez, Nathalia
    Rodriguez, Analiz
    JOURNAL OF NEURO-ONCOLOGY, 2021, 152 (03) : 451 - 466
  • [2] Central Nervous System Tumors in Adolescents and Young Adults: An Epidemiological Study from Jordan
    AlMuhaisen, GhadeerHayel
    Al-Tarawneh, Bushra
    Al-Hussaini, Maysa
    NEUROEPIDEMIOLOGY, 2020, 54 (04) : 326 - 333
  • [3] Health disparities and impact on outcomes in children with primary central nervous system solid tumors
    Austin, Mary T.
    Hamilton, Emma
    Zebda, Denna
    Hoang Nguyen
    Eberth, Jan M.
    Chang, Yuchia
    Elting, Linda S.
    Sandberg, David I.
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2016, 18 (05) : 585 - 593
  • [4] Late Effects of Treatment of Pediatric Central Nervous System Tumors
    Roddy, Erika
    Mueller, Sabine
    JOURNAL OF CHILD NEUROLOGY, 2016, 31 (02) : 237 - 254
  • [5] Defining and timing of palliative opportunities in children with central nervous system tumors
    Massie, A. McCauley
    Ebelhar, Jonathan
    Allen, Kristen E.
    DeGroote, Nicholas P.
    Wasilewski-Masker, Karen
    Brock, Katharine E.
    NEURO-ONCOLOGY PRACTICE, 2021, 8 (04) : 451 - 459
  • [6] Neighborhood Socioeconomic Deprivation and Mortality in Children with Central Nervous System Tumors
    Fahmideh, Maral Adel
    Schraw, Jeremy M.
    Chintagumpala, Murali
    Lupo, Philip J.
    Oluyomi, Abiodun Olufemi
    Scheurer, Michael E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (12) : 2278 - 2285
  • [7] Current Treatment Approaches for Infants with Malignant Central Nervous System Tumors
    Lafay-Cousin, Lucie
    Strother, Douglas
    ONCOLOGIST, 2009, 14 (04) : 433 - 444
  • [8] A system review of central nervous system tumors on children in China: epidemiology and clinical characteristics
    Yao, Bing
    Wang, Hongying
    Wu, Xiaomei
    Wang, Chenyu
    Tang, Tao
    An, Wenxiu
    Zhu, Bo
    BMC CANCER, 2024, 24 (01)
  • [9] Outcome of children and adolescents with central nervous system tumors in phase I trials
    Carceller, Fernando
    Bautista, Francisco
    Jimenez, Irene
    Hladun-Alvaro, Raquel
    Giraud, Cecile
    Bergamaschi, Luca
    Dandapani, Madhumita
    Aerts, Isabelle
    Doz, Francois
    Frappaz, Didier
    Casanova, Michela
    Morland, Bruce
    Hargrave, Darren R.
    Vassal, Gilles
    Pearson, Andrew D. J.
    Geoerger, Birgit
    Moreno, Lucas
    Marshall, Lynley V.
    JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (01) : 83 - 92
  • [10] Prolonged Use of Nimotuzumab in Children with Central Nervous System Tumors: Safety and Feasibility
    Cabanas, Ricardo
    Saurez, Giselle
    Alert, Jose
    Reyes, Adnolys
    Valdes, Jose
    Caridad Gonzalez, Maria
    Luis Pedrayes, Jorge
    Valle, Luis
    Infante, Mariela
    Avila, Melba
    Herrera, Raisa
    Hechavarria, Ernesto
    Rios, Marta
    Fernandez, Aymara
    Lorenzo Luaces, Patricia
    Crombet Ramos, Tania
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2014, 29 (04) : 173 - 178